Kuros Biosciences AG / Fundamentals
Income statement
- Net revenue
€118.11M - Cost of goods sold
€16.09M - Gross profit
€102.02M - SG&A expenses
€98.05M - R&D expenses
€13.62M - EBITDA
-€6.71M - D&A
€5.77M - EBIT
-€9.65M - Interest expenses
€5.59M - EBT
-€18.07M - Tax expenses
€811.78K - Net income
-€19.50M
Cash flow statement
- Net deferred tax
-€6.47M - Non-cash items
€28.05M - Changes in working capital
-€7.53M - Operating cash flow
-€6.17M - Capex
€1.56M - Other investing cash flow
-€4.87K - Net investing cash flow
-€1.56M - Total cash dividends paid
€0.00 - Issuance of common stock
€2.64M - Debt repayment
€0.00 - Other financing cash flow
-€1.38M - Net financing cash flow
€1.26M - Foreign exchange effects
-€279.25K - Net change in cash
-€10.59M - Cash at end of period
€19.51M - Free cash flow
-€4.62M
Balance sheet
- Cash and cash equivalents
€18.90M - Cash and short-term investments
€18.90M - Total receivables
€16.16M - Inventory
€10.22M - Other current assets
€3.16M - Total current assets
€48.44M - Property, plant & equipment
€3.27M - Goodwill
€21.03M - Intangible assets
€16.23M - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€43.06M - Total assets
€91.50M - Accounts payable
€7.48M - Short-term debt
€572.57K - Other current liabilities
€14.57M - Total current liabilities
€22.62M - Long-term debt
€1.37M - Deferred tax liabilities
€358.26K - Other non-current liabilities
€3.57M - Total non-current liabilities
€5.29M - Total liabilities
€27.91M - Common stock
€4.10M - Retained earnings
-€49.17M - Other equity
€0.00 - Total equity
€63.59M - Total liabilities and shareholders' equity
€91.50M
Company information
- Market capitalization
€1.16B - Employees
122 - Enterprise Value
€1.03B
Company ratios
- Gross margin
-
86.4% Much better than peer group: -256.1% - EBITDA margin
-
-5.7% Much better than peer group: -1,141.1% - EBIT margin
-
-8.2% Much better than peer group: -1,229.2% - EBT margin
-
-15.3% Much better than peer group: -1,243.4% - Net margin
-
-16.5% Much better than peer group: -1,166.0% - ROE
-
-30.7% Much better than peer group: -351.6% - ROA
-
-21.3% Much better than peer group: -84.1% - Asset turnover
-
129.1% Much better than peer group: 32.4% - FCF margin
-
-6.5% Much better than peer group: -1,055.0% - FCF yield
-0.7% - Efficiency ratio
105.7% - Net sales per employee
-
€968.09K - Net income per employee
-
-€159.84K